Scintigraphy in Thyroid Nodular Pathology
Thyroid scintigraphy is a method that formed more than 60 years ago and retains its importance for the diagnosis and assessment of the risk of nodular malignancy. The review examines the use of the scintigraphic method in functional and metabolic assessment of nodular goiter. Prerequisites for funct...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Luchevaya Diagnostika, LLC
2022-10-01
|
Series: | Вестник рентгенологии и радиологии |
Subjects: | |
Online Access: | https://www.russianradiology.ru/jour/article/view/747 |
_version_ | 1797341591054057472 |
---|---|
author | S. P. Mironov V. B. Sergienko |
author_facet | S. P. Mironov V. B. Sergienko |
author_sort | S. P. Mironov |
collection | DOAJ |
description | Thyroid scintigraphy is a method that formed more than 60 years ago and retains its importance for the diagnosis and assessment of the risk of nodular malignancy. The review examines the use of the scintigraphic method in functional and metabolic assessment of nodular goiter. Prerequisites for functional thyroid nodes screening with short-lived 99mTc-pertechnetate are outlined. Information is provided on the principles of its preparation and pharmacokinetics, as well as variants of the thyroid nodes functional activity, their possible malignant potential and indications for metabolic screening. The characteristic of metabolic activity allows to assess the risk of functionally “cold” thyroid nodes malignancy. The main stages of the use of nonspecific tumorotropic radiopharmaceuticals, the mechanism of their accumulation and metabolism in the thyroid tumors, the possibilities of the differential diagnosis of various types of nodular formations are presented. Modern views on the diagnostic capabilities of two-phase scintigraphy with 99mTс-methylisobutylisonitrile are reflected taking into account the relationship of radiopharmaceuticals accumulation with factors of proliferative activity and ultrastructural cell types, a variant of oncocytic pathology and multidrug-resistant protein expression. |
first_indexed | 2024-03-08T10:21:17Z |
format | Article |
id | doaj.art-02c1edbf0e3d454db4be4258694cb225 |
institution | Directory Open Access Journal |
issn | 0042-4676 2619-0478 |
language | English |
last_indexed | 2024-03-08T10:21:17Z |
publishDate | 2022-10-01 |
publisher | Luchevaya Diagnostika, LLC |
record_format | Article |
series | Вестник рентгенологии и радиологии |
spelling | doaj.art-02c1edbf0e3d454db4be4258694cb2252024-01-27T18:38:37ZengLuchevaya Diagnostika, LLCВестник рентгенологии и радиологии0042-46762619-04782022-10-011034-610811610.20862/0042-4676-2022-103-4-6-108-116425Scintigraphy in Thyroid Nodular PathologyS. P. Mironov0V. B. Sergienko1Myasnikov Research Institute of Clinical Cardiology, Chyazov National Medical Research Center for CardiologyMyasnikov Research Institute of Clinical Cardiology, Chyazov National Medical Research Center for CardiologyThyroid scintigraphy is a method that formed more than 60 years ago and retains its importance for the diagnosis and assessment of the risk of nodular malignancy. The review examines the use of the scintigraphic method in functional and metabolic assessment of nodular goiter. Prerequisites for functional thyroid nodes screening with short-lived 99mTc-pertechnetate are outlined. Information is provided on the principles of its preparation and pharmacokinetics, as well as variants of the thyroid nodes functional activity, their possible malignant potential and indications for metabolic screening. The characteristic of metabolic activity allows to assess the risk of functionally “cold” thyroid nodes malignancy. The main stages of the use of nonspecific tumorotropic radiopharmaceuticals, the mechanism of their accumulation and metabolism in the thyroid tumors, the possibilities of the differential diagnosis of various types of nodular formations are presented. Modern views on the diagnostic capabilities of two-phase scintigraphy with 99mTс-methylisobutylisonitrile are reflected taking into account the relationship of radiopharmaceuticals accumulation with factors of proliferative activity and ultrastructural cell types, a variant of oncocytic pathology and multidrug-resistant protein expression.https://www.russianradiology.ru/jour/article/view/747thyroid scintigraphynodular goiterrisk of malignancyrеview |
spellingShingle | S. P. Mironov V. B. Sergienko Scintigraphy in Thyroid Nodular Pathology Вестник рентгенологии и радиологии thyroid scintigraphy nodular goiter risk of malignancy rеview |
title | Scintigraphy in Thyroid Nodular Pathology |
title_full | Scintigraphy in Thyroid Nodular Pathology |
title_fullStr | Scintigraphy in Thyroid Nodular Pathology |
title_full_unstemmed | Scintigraphy in Thyroid Nodular Pathology |
title_short | Scintigraphy in Thyroid Nodular Pathology |
title_sort | scintigraphy in thyroid nodular pathology |
topic | thyroid scintigraphy nodular goiter risk of malignancy rеview |
url | https://www.russianradiology.ru/jour/article/view/747 |
work_keys_str_mv | AT spmironov scintigraphyinthyroidnodularpathology AT vbsergienko scintigraphyinthyroidnodularpathology |